Home › Major Depressive Disorder › Virginia
Pag-aaral pangklinika para sa Major Depressive Disorder sa Virginia
7 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa Virginia.
Mga Lungsod sa Virginia
Opisyal na teksto ng pag-aaral (English)
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Re:Cognition Health, Fairfax
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07412756Study of ALTO-300 in MDD
- Site 277, Fairfax
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT05922878A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Roanoke
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07196501A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Richmond
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07105111Evaluating Conversational Artificial Intelligence for Depression Management
- George Mason University, Fairfax
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07105397NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Charlottesville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06911112Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #145, Fairfax
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06633016Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.